JANX
Janux Therapeutics Inc Earnings
$14.45
Earnings Summary
Revenue | $10Mn |
Net Profits | $-24.31Mn |
Net Profit Margins | -243.13% |
Janux Therapeutics Inc’s revenue jumped 2177.9% since last year same period to $10Mn in the Q3 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated +Inf% jump in its revenue since last 3-months.
Janux Therapeutics Inc’s net profit jumped 13.35% since last year same period to $-24.31Mn in the Q3 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated 28.19% jump in its net profits since last 3-months.
Janux Therapeutics Inc’s net profit margin jumped 96.2% since last year same period to -243.13% in the Q3 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.7 |
EPS Estimate Current Year | -0.7 |
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.7 - a -13.36% fall from last quarter’s estimates.
Janux Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.7.
Key Ratios
Earning Per Share (EPS) | 0 |
Janux Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2025. This indicates that the Janux Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-07 | -0.46 | -0.55 | -19.25% |
2025-11-06 | -0.62 | -0.39 | 36.82% |
2026-03-06 | -0.7 | 0 | 100% |
2025-05-08 | -0.39 | -0.38 | 2.99% |
